Arecor Therapeutics plc (LON:AREC – Get Free Report)’s stock price reached a new 52-week low on Wednesday . The stock traded as low as GBX 48 ($0.62) and last traded at GBX 48 ($0.62), with a volume of 264564 shares trading hands. The stock had previously closed at GBX 50.50 ($0.65).
Arecor Therapeutics Price Performance
The company has a current ratio of 1.37, a quick ratio of 6.24 and a debt-to-equity ratio of 5.51. The firm has a market cap of £19.78 million, a P/E ratio of -1.85 and a beta of -0.18. The company has a fifty day moving average price of GBX 58.53 and a two-hundred day moving average price of GBX 69.
About Arecor Therapeutics
Arecor Therapeutics plc is a globally focused biopharmaceutical company transforming patient care by bringing innovative medicines to market through the enhancement of existing therapeutic products. By applying our innovative proprietary technology platform, Arestat™, we are developing an internal portfolio of proprietary products in diabetes and other indications, as well as working with leading pharmaceutical and biotechnology companies to deliver therapeutic products.
Featured Stories
- Five stocks we like better than Arecor Therapeutics
- What Are Trending Stocks? Trending Stocks Explained
- Is Myers Industries Poised for a Breakout?
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Retail Stocks Investing, Explained
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
